Tags : Filgotinib (JAK1i)

Shots: The P-II TORTUGA study is assessing safety and efficacy in moderate to severe ankylosing spondylitis (AS) adults in ratio of 1:1 administering filgotinib 200 mg or PBO qw for 12 wks. TORTUGA results (N=116): improvement in AS disease, ASAS20 response (76% vs 40%), ASDAS (-1.5 vs -0.6) with no new safety signals and deaths […]Read More